Back

Patient-reported experiences with icosapent ethyl in adults with type 2 diabetes: Insights from a UK primary care survey

24 April 2026 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Predicting and managing diabetes-associated cardiovascular risk Diabetes and the Heart EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mrs Meredith Donaldson

Marsh Medical Practice, Louth (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Acylcarnitines as early predictors of 10-year diabetes risk in a population-based apparently healthy cohort
Doctor K. Maung (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Protein-protein interaction network construction and analysis to identify synergistic effects for sodium-glucose cotransporter-2, glucagon-like peptide-1 and mineralocorticoid receptor
Professor G. Tse (Hong Kong, CN)
Abstract Slides
Presentation thumbnail
Bridging guidelines to practice: digital health platform identifies central adiposity as dominant driver of insulin resistance in real-world prevention settings
Doctor B. Jiravska Godula (Trinec, CZ)
Abstract Slides
Presentation thumbnail
Multiblock proteomic profiling of the molecular link between prediabetes and preclinical atherosclerosis in apparently healthy adults
Doctor N. Zieleniewska (Bialystok, PL)
Abstract Slides
Presentation thumbnail
Association of body mass index (BMI) with 10-yr QRISK2 score for cardiovascular diseases (CVD) in asian indians with type-2 diabetes (T2D): analysis of india heart watch (IHW)
Associate Professor L. Guptha (Ivins, US) Doctor S. Guptha (St George, US)
Abstract Slides

Access the full session

Session thumbnail
Predicting and managing diabetes-associated cardiovascular risk

The Event

Event poster

ESC Preventive Cardiology 2026

24 April 2026 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Patient-reported experiences after ASCVD hospitalisation: results from the insights from patients living with elevated cholesterol (IPEC) study
13 June 2025
thumbnail
Congress Presentation
Cardiovascular risk reduction & hypertriglyceridemia: integrating the evidence
29 August 2025
thumbnail
Congress Presentation
A collaborative working project in primary care: optimising lipid lowering therapies for secondary prevention in high risk patients
4 April 2025
thumbnail
Congress Presentation
REDUCE-IT: outcomes by baseline statin type
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources